3 14

Cited 0 times in

Cited 0 times in

A Multi-Center, Prospective, Observational Study to Evaluate the Therapeutic Effectiveness and Safety of an Olmesartan/Amlodipine Plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia

DC Field Value Language
dc.contributor.authorLee, Bong-Ki-
dc.contributor.authorKim, Byeong-Keuk-
dc.contributor.authorPark, Jae Hyoung-
dc.contributor.authorChung, Jong-Won-
dc.contributor.authorPark, Chang Gyu-
dc.contributor.authorKim, Jin Won-
dc.contributor.authorKim, Young Dae-
dc.contributor.authorPark, Woo-Jung-
dc.contributor.authorKim, Sang-Hyun-
dc.contributor.authorCha, Jae-Kwan-
dc.contributor.authorKim, Cheol Ho-
dc.contributor.authorRha, Seung-Woon-
dc.contributor.authorHong, Young Joon-
dc.contributor.authorShin, Mi-Seung-
dc.contributor.authorCho, Seong Wook-
dc.contributor.authorSung, Young-Hee-
dc.contributor.authorLee, Kiheon-
dc.contributor.authorYu, Jae-Myung-
dc.contributor.authorRyu, Dong-Ryeol-
dc.contributor.authorYu, Sungwook-
dc.contributor.authorSong, Tae-Jin-
dc.contributor.authorKu, Bon D.-
dc.contributor.authorKim, Sin-Gon-
dc.contributor.authorPark, Hwan-Cheol-
dc.contributor.authorCho, Deok-Kyu-
dc.contributor.authorKim, Byung-Su-
dc.contributor.authorHan, Seong-Woo-
dc.contributor.authorPark, Sung-Ji-
dc.contributor.authorPark, Gyung-Min-
dc.contributor.authorHan, Kyoo-Rok-
dc.date.accessioned2025-11-13T01:45:41Z-
dc.date.available2025-11-13T01:45:41Z-
dc.date.created2025-07-16-
dc.date.issued2025-01-
dc.identifier.issn2077-0383-
dc.identifier.urihttps://ir.ymlib.yonsei.ac.kr/handle/22282913/208733-
dc.description.abstractIntroduction: This study assessed the therapeutic effectiveness of a single-pill combination (SPC) of olmesartan/amlodipine plus rosuvastatin for blood pressure (BP) and low-density lipoprotein cholesterol (LDL-C) in patients with hypertension and dyslipidemia. Methods: Adult patients with hypertension and dyslipidemia who were decided to be treated with the study drug were eligible. The primary endpoint was the proportion of patients who achieved BP, LDL-C and both BP and LDL-C treatment goals at weeks 24-48. Secondary endpoints were assessed at weeks 24-48 and included changes in BP and LDL-C levels from baseline; the proportion of patients who achieved treatment goals who were initially classified as uncontrolled at baseline; changes and percent changes in lipid parameters; changes in both BP and LDL-C levels among patients who reached treatment goals who were followed for more than 24 weeks; and the overall safety profile. Results: A total of 5476 patients were enrolled, and 4411 patients comprised the effectiveness evaluation set. The proportions of patients who reached the treatment goals for BP, LDL-C levels, and both BP and LDL-C levels were 67.93% [95% confidence interval (CI) 66.52-69.32], 80.19% [95% CI 78.85-81.49], and 58.07% [95% CI 56.43-59.7], respectively. Secondary endpoints showed statistically significant changes. Overall, the treatment was well tolerated. Conclusions: The treatment of patients with hypertension and dyslipidemia with the olmesartan/amlodipine plus rosuvastatin SPC was associated with significant decreases in SBP/DBP and LDL-C levels, and a high proportion of patients achieved the BP and LDL-C treatment goals. The finding of this study is worthwhile in that this study evaluated the effectiveness and safety in a broad patient population representative of those seen in everyday clinical practice.-
dc.formatapplication/pdf-
dc.languageEnglish-
dc.publisherMDPI AG-
dc.relation.isPartOfJOURNAL OF CLINICAL MEDICINE-
dc.relation.isPartOfJOURNAL OF CLINICAL MEDICINE-
dc.titleA Multi-Center, Prospective, Observational Study to Evaluate the Therapeutic Effectiveness and Safety of an Olmesartan/Amlodipine Plus Rosuvastatin Combination Treatment in Patients with Concomitant Hypertension and Dyslipidemia-
dc.typeArticle-
dc.contributor.googleauthorLee, Bong-Ki-
dc.contributor.googleauthorKim, Byeong-Keuk-
dc.contributor.googleauthorPark, Jae Hyoung-
dc.contributor.googleauthorChung, Jong-Won-
dc.contributor.googleauthorPark, Chang Gyu-
dc.contributor.googleauthorKim, Jin Won-
dc.contributor.googleauthorKim, Young Dae-
dc.contributor.googleauthorPark, Woo-Jung-
dc.contributor.googleauthorKim, Sang-Hyun-
dc.contributor.googleauthorCha, Jae-Kwan-
dc.contributor.googleauthorKim, Cheol Ho-
dc.contributor.googleauthorRha, Seung-Woon-
dc.contributor.googleauthorHong, Young Joon-
dc.contributor.googleauthorShin, Mi-Seung-
dc.contributor.googleauthorCho, Seong Wook-
dc.contributor.googleauthorSung, Young-Hee-
dc.contributor.googleauthorLee, Kiheon-
dc.contributor.googleauthorYu, Jae-Myung-
dc.contributor.googleauthorRyu, Dong-Ryeol-
dc.contributor.googleauthorYu, Sungwook-
dc.contributor.googleauthorSong, Tae-Jin-
dc.contributor.googleauthorKu, Bon D.-
dc.contributor.googleauthorKim, Sin-Gon-
dc.contributor.googleauthorPark, Hwan-Cheol-
dc.contributor.googleauthorCho, Deok-Kyu-
dc.contributor.googleauthorKim, Byung-Su-
dc.contributor.googleauthorHan, Seong-Woo-
dc.contributor.googleauthorPark, Sung-Ji-
dc.contributor.googleauthorPark, Gyung-Min-
dc.contributor.googleauthorHan, Kyoo-Rok-
dc.identifier.doi10.3390/jcm14020308-
dc.relation.journalcodeJ03556-
dc.identifier.eissn2077-0383-
dc.identifier.pmid39860313-
dc.subject.keywordhypertension-
dc.subject.keyworddyslipidemia-
dc.subject.keywordblood pressure-
dc.subject.keywordlow-density lipoprotein cholesterol-
dc.subject.keywordobservational study-
dc.subject.keywordsingle-pill combination-
dc.contributor.affiliatedAuthorKim, Byeong-Keuk-
dc.contributor.affiliatedAuthorCho, Deok-Kyu-
dc.identifier.scopusid2-s2.0-85216097096-
dc.identifier.wosid001404209100001-
dc.citation.volume14-
dc.citation.number2-
dc.identifier.bibliographicCitationJOURNAL OF CLINICAL MEDICINE, Vol.14(2), 2025-01-
dc.identifier.rimsid87952-
dc.type.rimsART-
dc.description.journalClass1-
dc.description.journalClass1-
dc.subject.keywordAuthorhypertension-
dc.subject.keywordAuthordyslipidemia-
dc.subject.keywordAuthorblood pressure-
dc.subject.keywordAuthorlow-density lipoprotein cholesterol-
dc.subject.keywordAuthorobservational study-
dc.subject.keywordAuthorsingle-pill combination-
dc.subject.keywordPlusFIXED-DOSE COMBINATION-
dc.subject.keywordPlusTASK-FORCE-
dc.subject.keywordPlusPREVENTION-
dc.subject.keywordPlusCHOLESTEROL-
dc.subject.keywordPlusOLMESARTAN-
dc.subject.keywordPlusMANAGEMENT-
dc.subject.keywordPlusADHERENCE-
dc.type.docTypeArticle-
dc.description.isOpenAccessY-
dc.description.journalRegisteredClassscie-
dc.description.journalRegisteredClassscopus-
dc.relation.journalWebOfScienceCategoryMedicine, General & Internal-
dc.relation.journalResearchAreaGeneral & Internal Medicine-
dc.identifier.articleno308-
Appears in Collections:
1. College of Medicine (의과대학) > Dept. of Internal Medicine (내과학교실) > 1. Journal Papers

qrcode

Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.